Your session is about to expire
← Back to Search
Propofol for Migraine (Propofol2014 Trial)
Propofol2014 Trial Summary
This trial will study the use of low-dose propofol to treat migraines in children. The goal is to see if it is effective and safe, and to determine the best dose.
- Migraine
Propofol2014 Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Propofol2014 Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Is there an upper age-limit for applicants to this experiment?
"To qualify for this trial, applicants need to be between 7 and 18 years old. Additionally, there are 55 clinical trials designed specifically for minors and 239 studies intended for the elderly population."
What maladies is Propofol commonly administered to address?
"Propofol is a commonly used sedative for medical procedures, as well as monitored anesthesia care therapy, sedative therapy and other anesthetic operations."
Is this trial currently accepting new participants?
"Confirmed. According to the information presented on clinicaltrials.gov, this medical trial was first posted in June 2015 and is currently seeking volunteers for participation. 40 individuals need to be enrolled at a single site."
Is it feasible for me to participate in this experiment?
"Individuals aged between 7 and 18 years old with a diagnosis of migraine can register for this medical trial. 40 participants in total are being accepted by the research team."
What is the cumulative amount of participants enrolled in this research project?
"Affirmative. Clinicaltrials.gov is displaying that this research initiative, which was published on June 1st 2015, is actively seeking participants. Approximately 40 volunteers must be identified at one medical centre."
What other investigations have been conducted to assess the effects of Propofol?
"Currently, 12 Propofol studies are in Phase 3 with an additional 72 trials still being conducted. In particular, Jinan Shandong is the major hub of research for this medication while there also exist 251 other study locations worldwide."
Share this study with friends
Copy Link
Messenger